Dr. Savani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-936-2000Fax+1 615-936-0605
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2003 - 2007
- UMass Chan Medical SchoolResidency, Internal Medicine, 2001 - 2003
- B. J. Medical College AhmedabadClass of 1989
Certifications & Licensure
- NH State Medical License 2003 - Present
- TN State Medical License 2007 - 2026
- MD State Medical License 2003 - 2013
- AR State Medical License 2006 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions.Jeremy W Jacobs, Garrett S Booth, Sheharyar Raza, Landon M Clark, Ross M Fasano
American Journal of Hematology. 2024-12-01 - Progressive multifocal leukoencephalopathy after CAR-T cell therapy.Michael Montoya, Hannah J Harmsen, Brittney Baer, Nancy Long, Amy Messimore
Bone Marrow Transplantation. 2024-12-01 - Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients.Geoffrey Cheng, Michael A Smith, Rachel Phelan, Ruta Brazauskas, Joelle Strom
Transplantation and Cellular Therapy. 2024-10-01
Journal Articles
- The European Society for Blood and Marrow Transplantation (EBMT) Consensus Recommendations for Donor Selection in Haploidentical Hematopoietic Cell TransplantationLeo Luznik, Karen Ballen, Asad Bashey, Hillard M Lazarus, Bipin N Savani, Rizwan Romee, Ephraim J Fuchs, Nature
- Prophylactic Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplantation in Acute Leukaemia – a Matched Pair Analysis by the Acute Leukaemia Working Party of ...Bipin Savani, MD, British Journal of Haematology
- Post-Remission Strategies for the Prevention of Relapse Following Allogeneic Hematopoietic Cell Transplantation for High-Risk Acute Myeloid Leukemia: Expert Review fro...Catherine J Lee, Bipin N Savani, Nature
- Join now to see all
Abstracts/Posters
- Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from...Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Lower Hematopoietic Progenitor Cell Counts and Yields at Subsequent Donations Is Influenced By a Shorter Inter-Donation Interval between the First and Subsequent Mobil...Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transpl...Bipin N. Savani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia in First Complete Remission Undergoing Allogeneic Stem Cell Transplantation from 10/10 HLA-Matched Unrelated DonorsJuly 3rd, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: